Results 241 to 250 of about 80,628 (293)

Crosstalk Between CTSB+ Glioblastoma Cells and S100A10+ Macrophages: A Self‐Reinforcing Circuit Promotes Immune Evasion and Limits Response to Immunotherapy

open access: yesAdvanced Science, EarlyView.
In glioblastoma, M2‐polarized macrophages secrete IL‐6, which activates STAT3 signaling in tumor cells to upregulate CTSB. Tumor‐derived CTSB binds the C‐terminus of macrophage S100A10, reinforcing M2 polarization and further IL‐6 secretion, thereby establishing a feedforward IL‐6/STAT3/CTSB/S100A10 loop. This cascade drives tumor growth, invasion, and
Hao Zhang   +11 more
wiley   +1 more source

[The new interleukins].

open access: yesAnnali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 1990
openaire   +2 more sources

Mast Cells and Interleukins [PDF]

open access: yesInternational Journal of Molecular Sciences, 2022
Mast cells play a critical role in inflammatory diseases and tumor growth. The versatility of mast cells is reflected in their ability to secrete a wide range of biologically active cytokines, including interleukins, chemokines, lipid mediators ...
Antonio Giovanni Solimando   +2 more
exaly   +2 more sources

Interleukins in Urine and Blood as Markers of Infection and as Risk Factors for Systemic Conditions [PDF]

open access: yesEuropean Urology Focus
Interleukins are a diverse group of cytokines that play a crucial role in controlling immune responses and have potential as biomarkers. This mini review evaluates 12 recent papers linking urinary interleukins to both urinary infection and systemic ...
Richard Luxton, Janice Kiely
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Interleukins

Annual Review of Medicine, 1986
Interleukins are polypeptides that act on leukocytes and other tissue targets. Interleukin-1, produced by macrophages and other cells, activates lymphocytes and also induces several components of the host's acute-phase response to infection and injury. Interleukin-2, produced by T lymphocytes, is a growth factor for helper, suppressor, and cytotoxic T ...
C A, Dinarello, J W, Mier
openaire   +2 more sources

Interleukin 5

Advances in Neuroimmunology, 1992
Interleukin-5 is a dimeric cytokine that controls the differentiation of B cells into antibody-secreting cells as well as inducing the growth of Ly-1(CD5)+ B cells and B-cell tumors. It also has a major role of the growth and differentiation of eosinophils.
A N, McKenzie, C J, Sanderson
openaire   +4 more sources

Interleukin 1: the first interleukin

Immunology Today, 1990
The name 'interleukin' and the designation of interleukin 1 (IL-1) derived from the Second International Lymphokine Workshop held in Switzerland in 1979. Since then interest in the original interleukin (IL-1) has increased exponentially as measured by the numbers of publications and meetings.
F S, di Giovine, G W, Duff
openaire   +2 more sources

Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy

Cytokine, 1995
The objective of this study was to investigate the in vivo production of interleukin 10 (IL-10) in cancer patients undergoing immunotherapy with IL-1 alpha, IL-2 or IL-6 and to study the effect of the same cytokines on the in vitro synthesis of IL-10 by human monocytes and macrophages. In the IL-1 alpha clinical trial, patients received 0.03 g/kg of IL-
H, Tilg   +3 more
openaire   +2 more sources

Interleukin-2, Interleukin-15, and Their Receptors

International Reviews of Immunology, 1998
Both IL-15 and IL-2 are 14-15 kDa members of the four alpha-helical bundle family of cytokines that have T cell growth factor activity. In contrast to the pattern manifested by IL-2, IL-15 mRNA is produced by a wide variety of tissues other than T cells. We have demonstrated that IL-15 expression is posttranscriptionally regulated by multiple elements,
T, Waldmann, Y, Tagaya, R, Bamford
openaire   +2 more sources

Home - About - Disclaimer - Privacy